The Department of Health-Abu Dhabi (DoH) has launched the Newborn Genetic Screening Programme, a groundbreaking initiative that uses whole genome sequencing and artificial intelligence to detect more than 815 treatable childhood genetic conditions. The programme, one of the most comprehensive of its kind globally, is aligned with the Emirati Genome Council’s vision to advance personalised and precision healthcare in the region.
The first phase has been rolled out at Kanad Hospital and Danat Al Emarat Hospital, with plans to expand across all maternity hospitals in the emirate. Screening will be offered to UAE Nationals and children of Emirati mothers, providing families with crucial insights into their newborns’ health.
By testing cord blood samples at birth, the programme enables early detection of serious conditions, such as metabolic disorders, immune deficiencies and spinal muscular atrophy, which can be treated effectively if identified early. Results are provided within 21 days, alongside genetic counselling and referrals to specialists when needed.
Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, said, “Healthcare begins long before symptoms appear, and today, empowered by science and technology, we can act earlier than ever before".